Key facts
- This page summarizes Albert Bourla's Form 4 filing for PFIZER INC (PFE).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 01 Apr 2022, 15:43.
Albert Bourla - 31 Mar 2022 Form 4 Insider Report for PFIZER INC (PFE)
- Signature
- Susan E. Grant, by power of atty., for Albert Bourla
- Issuer symbol
- PFE
- Transactions as of
- 31 Mar 2022
- Net transactions value
- +$512
- Form type
- 4
- Filing time
- 01 Apr 2022, 15:43:50 UTC
- Previous filing
- 17 Mar 2022
- Next filing
- 14 Apr 2022
- SEC
- View on sec.gov
Key filing fact
Albert Bourla filed Form 4 for PFIZER INC (PFE) on 01 Apr 2022.
Change
- Previous filing in this sequence was filed on 17 Mar 2022.
- Current net transaction value: +$512.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
PFE
transaction
Derivative
Phantom Stock Units SSP
Award
- Transaction value
- $512
- Shares
- +10
- Change %
- +0.01%
- Price
- $51.18
- Shares after
- 93,107
- Date
- 31 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10
- Exercise price
- Footnotes
- F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Each unit represents one phantom share of common stock. |
| F2 | These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |